Steris (STE) Net Income towards Common Stockholders (2018 - 2025)
Steris' (STE) quarterly Net Income towards Common Stockholders came in at -$800000.0 in Q1 2025, up 99.48% year-on-year from -$401039.6 in Q1 2024, and down 700.0% quarter-over-quarter from -$100000.0 in Q4 2024.
Steris (STE) Net Income towards Common Stockholders (2018 - 2025) Analysis & Trends
Steris' Net Income towards Common Stockholders history runs 8 years deep, the most recent figure standing at -$800000.0 for Q1 2025.
- On a quarterly basis, Net Income towards Common Stockholders rose 99.48% year-over-year to -$800000.0 in Q1 2025; TTM through Dec 2025 was -$800000.0, a 99.46% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 102.6% from the prior year.
- Net Income towards Common Stockholders fell to -$800000.0 in Q1 2025 per STE's latest filing, from -$100000.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $143.1 million in Q4 2021 and bottomed at -$439.1 million in Q3 2022.
- The 5-year median for Net Income towards Common Stockholders is -$800000.0 (2025), against an average of -$14.6 million.
- Biggest YoY gain for Net Income towards Common Stockholders was 182.46% in 2024; the steepest drop was 3338.22% in 2024.
- Year by year, Net Income towards Common Stockholders stood at $143.1 million in 2021, then slumped by 105.37% to -$7.7 million in 2022, then increased by 0.29% to -$7.7 million in 2023, then soared by 98.69% to -$100000.0 in 2024, then slumped by 700.0% to -$800000.0 in 2025.
- Per Business Quant, the three latest STE Net Income towards Common Stockholders figures stand at -$800000.0 (Q1 2025), -$100000.0 (Q4 2024), and -$200000.0 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 186.78 Bn | 179.48 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 131.95 Bn | 129.07 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 111.27 Bn | 102.05 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.63 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.23 Bn | 26.94 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.90 Bn | 27.78 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 28.19 Bn | 27.62 Bn | - | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 171.83 Mn |
| 10 | Steris | 22.55 Bn | 22.11 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -800,000.00 |
| Dec 31, 2024 | -100,000.00 |
| Sep 30, 2024 | -200,000.00 |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | -154.30 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -4.45 Mn |
| Jun 30, 2023 | -6.79 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | -7.68 Mn |
| Sep 30, 2022 | -439.14 Mn |
| Jun 30, 2022 | -8.33 Mn |
| Mar 31, 2022 | 93.64 Mn |
| Dec 31, 2021 | 143.09 Mn |
| Sep 30, 2021 | 69.63 Mn |
| Jun 30, 2021 | -21.90 Mn |
| Mar 31, 2021 | 86.74 Mn |
| Dec 31, 2020 | 114.59 Mn |
| Sep 30, 2020 | 106.01 Mn |
| Jun 30, 2020 | 89.53 Mn |